Cost‐Effectiveness of a Potential ProphylacticHelicobacter pyloriVaccine in the United States

Abstract
BackgroundHelicobacter pylori vaccines are under development to prevent infection. We quantified the cost-effectiveness of such a vaccine in the Unit